Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cook eyes December launch for pelvic congestion syndrome diagnostic:

This article was originally published in Clinica

Executive Summary

Cook Women's Health plans to complete the CE-marking of its transcervical pelvic venogram (TPV) set for diagnosing pelvic congestion syndrome (PCS), by December 2006. The test, which is already approved in the US for performing basic hysterograms and transcervical venography, works by injecting a water-soluble, radiopaque contrast medium into the fundal myometrium at the top of the uterus. The medium is picked up by the veins and then monitored using fluoroscopic imaging. PCS is characterised by hyperdilated vasculature and poor clearance of the dye. PCS is one of the many causes of chronic pelvic pain, and affects around 15% of women aged 18-50, claims Cook.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053509

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel